摘要
慢性肺原性心脏病顽固性心衰的临床治疗是非常困难的 ,其死亡率也是比较高的。在临床上通过应用生脉注射液和多巴酚丁胺联合用药治疗肺心病顽固性心衰取得较好的疗效。通过对 30例病人的治疗 ,总有效率为 93.33% 。
The clinical treatment for intractable heart failure of chronic cor pulmonale is very difficult,and the death rate of this disease is higher.Using Shenmai injecting liquid and dobutamine jointly to treat the intractable heart failure of pulmonary heart diseases has obtained better curative effect.Through the treatment for 30 cases of the patients,the total effectiveness rate reaches to 93.33%.This therapy is worth spreading and applying clinically.
出处
《科技情报开发与经济》
2000年第6期95-96,共2页
Sci-Tech Information Development & Economy
关键词
肺心病
顽固性心衰
生脉注射液
多巴酚丁胺
治疗
pulmonary heart diseases
intractable heart failure
Shenmai injecting liquid
dobutamine